[1]
“The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor haematopoietic stem cell transplantation for myeloid malignancies”, Swiss Med Wkly, vol. 143, no. 0102, p. w13717, Dec. 2012, doi: 10.4414/smw.2013.13717.